Egypt reports 2,210 COVID cases Sunday to set another record high for 6th day in a row

Ahram Online , Monday 31 Jan 2022

Egypt reported 2,210 COVID cases on Sunday to set another record high for 6th day in a row as the country continues to battle a surge in infections.

Egyptian men wearing masks. File photo/AFP

Sunday's figures brought the total number of reported coronavirus cases in the country up to 423,688 since the outbreak of the pandemic in February 2020, according to Ministry of Health and Population's daily update.

The ministry also reported 38 new deaths in the past 24 hours, bringing the total fatalities nationwide to 22,604.

The ministry added that 1,974 patients have been discharged from hospitals after recovering from the virus, bringing the total number of recoveries to 356,274.

On Friday, Egypt surpassed the figure of 2,000 new coronavirus cases for first time since the outbreak of the pandemic.

In recent weeks, Egypt has implemented new preventative measures at airports, seaports and land crossings to control the surge in coronavirus cases.

Egypt has administered a total of 37,190,384 first vaccine doses and 25,928,356 second vaccine doses since the start of mass vaccination campaign in January of 2021, according to the health ministry’s daily statistics.

A total of 618,761 booster shots have been administered in recent weeks, as per the health ministry, bringing the total number of coronavirus vaccines administered since the start of the mass vaccination campaign to 63,737,501 jabs.

On Saturday, Egypt received 115,000 doses of the AstraZeneca coronavirus vaccine coming from Latvia.

Earlier this month, Presidential Adviser for Health Affairs Mohamed Awad Tag El-Din affirmed that the highly infectious coronavirus variant Omicron is responsible for the vast majority of new COVID cases in the country.

Egypt has imported tens of millions of doses of all major coronavirus vaccines, including Sinovac, Sinopharm, Sputnik V, Moderna, Pfizer and Johnson & Johnson and has opened 1,393 vaccination centres in all governorates.

The EDA also issued an emergency use authorisation for Merck’s COVID-19 drug Molnupiravir and allowed five national companies to manufacture the oral antiviral.

Short link: